Loading banners...

First Reta Phase III Results

Here is the link: Eli Lilly (Dec. 11, 2025). Lilly's triple agonist, retatrutide, delivered weight loss of up to an average of 71.2 lbs along with substantial relief from osteoarthritis pain in first successful Phase 3 trial. PR Newswire, https://www.prnewswire.com/news-rel...first-successful-phase-3-trial-302638804.html.

We'll have to wait until they present their results at a medical conference or through a scholarly article before we learn additional details.

Although I'll jump on the bandwagon and praise retatrutide as being the next huge weight loss drug to enter the market, I suspect that we will soon large numbers of new weight loss drugs get approved in the next five years.
 
Last edited:
It's even better than weight loss surgery, thanks for this.

There will be less need for weight loss surgery. Some folks will likely still require retatrutide to lose weight before the surgery and will have to resume taking reta at some point after the surgery.

It's good that weight loss surgery will be less necessary. I have read about and watched televisions about folks who have undergone weight loss surgery. Despite there being some side effects from GLP-1 and GLP-1+ medications, their side effects are usually nowhere close to being as severe as those from weight loss surgery.
 
Top Bottom